Clinical trial
Randomized Double Cord Blood Transplant Study
NCT00067002 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00067002 |
|---|---|
| Title | Randomized Double Cord Blood Transplant Study |
| Official title | Randomized Trial of Unmanipulated Versus Expanded Cord Blood |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH Cellgenix |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphocytic, Acute, Myelocytic, Myeloid, Chronic, Lymphoma, Non-Hodgkin |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | Expanded allogeneic cord blood (CB), One Unmanipulated and One Expanded Cord Blood Unit, Rituxan, Melphalan, Thiotepa, Fludarabine, Cyclophosphamide, Mesna, Total body irradiation (TBI) |
| Enrollment | 110 |
| Start date | Apr 1, 2003 |
| Primary completion | Jul 1, 2016 |
| Completion | Jul 1, 2016 |
| First posted | Aug 11, 2003 |
| Last update posted | May 1, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: